Public investments in environmental science are shown to be a major driver behind the UK’s wind industry. It delivers billions in economic value while also helping to protect the country’s marine environment.
Our climate is global and the challenge of preventing catastrophic environmental damage will require the cooperation of all nations - but is it too late to prevent climate change?
Teva and Cephalon faced the €60.5 million antitrust fine, after both companies were found to be actively suppressing the existence of cheaper medicine.
The European Centre for Disease Control (ECDC) and the World Health Organisation (WHO) found that HIV testing in Europe is not good enough - 53% of diagnosis happens when the immune system is already failing.
Simon Carter, Director at RM Education says that COVID-19 created deep-rooted education changes in the UK, and that we must now strengthen the world of online learning.
Pete Mills, Commercial Technical Operations Manager at Bosch Commercial & Industrial, outlines why a hybrid heating system is a better option than a full heat pump for district heating schemes.
360 Resourcing conducted a survey on workplace bias and found that it is still experienced by 86% of employees. Here they explore what society is missing when it comes to creating an unbiased working environment.
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
Morten Petersen, CEO and Co-Founder, Worksome, discusses how COVID-19 has transformed the world of work and enabled employers to find the best talent wherever its location may be.
Sascha Giese, Head Geek™ at SolarWinds, discusses some of the challenges the government faces with legacy technology and why public sector digital modernisation is long overdue.
Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, says this time is different and the TRIPS Council knows it - the COVID-19 vaccine needs to be freely accessible to all countries.